Gabriele Castelnuovo

Dr. Gabriele Castelnuovo

Medical of Medical Sciences, University of Turin, Turin, Piedmont, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
DODominic O'Connor
Dominic O'Connor
MPMichelle Pang
Michelle Pang
GCGabriele Castelnuovo
Gabriele Castelnuovo
GFGraham Finlayson
Graham Finlayson
EBEllen Blaak
Ellen Blaak
JMJ. Alfredo Martinez
J. Alfredo Martinez
The review focused on outcomes related to obesity an diabetes as affected by sweeteners and included the following keywords: Food Intake, Subjective Appetite, Food Hedonics/Reward, Body Weight, Energy and Glucose, Metabolism/Adiposity Markers.

5 June 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
NPNuria Perez-Diaz-del-Campo
Nuria Perez-Diaz-del-Campo
GCGabriele Castelnuovo
Gabriele Castelnuovo
Davide Giuseppe RibaldoneDavide Giuseppe Ribaldone
Davide Giuseppe Ribaldone
Gian Paolo CavigliaGian Paolo Caviglia
Gian Paolo Caviglia
The study of intestinal permeability is gaining growing interest due to its relevance in the onset and progression of several gastrointestinal and non-gastrointestinal diseases. Though the involvement of impaired intestinal permeability in the pathophysiology of such diseases is recognized, there is currently a need to identify non-invasive biomarkers or tools that are able to accurately detect alterations in intestinal barrier integrity. On the one hand, promising results have been reported for novel in vivo methods based on paracellular probes, i.e., methods that can directly assess paracellular permeability and, on the other hand, on fecal and circulating biomarkers able to indirectly assess epithelial barrier integrity and functionality. In this review, we aimed to summarize the current knowledge on the intestinal barrier and epithelial transport pathways and to provide an overview of the methods already available or currently under investigation for the measurement of intestinal permeability.

26 February 2023 in Appetite
Verified
Journal Article
Open access
EAEva Almiron-Roig
Eva Almiron-Roig
Santiago Navas-CarreteroSantiago Navas-Carretero
Santiago Navas-Carretero
GCGabriele Castelnuovo
Gabriele Castelnuovo
Louise KjølbækLouise Kjølbæk
Louise Kjølbæk
AHAna Romo Hualde
Ana Romo Hualde
JMJ. Alfredo Martinez
J. Alfredo Martinez
Project SWEET examined the barriers and facilitators to the use of non-nutritive sweeteners and sweetness enhancers (hereafter "S&SE") alongside potential risks/benefits for health and sustainability. The Beverages trial was a double-blind multi-centre, randomised crossover trial within SWEET evaluating the acute impact of three S&SE blends (plant-based and alternatives) vs. a sucrose control on glycaemic response, food intake, appetite sensations and safety after a carbohydrate-rich breakfast meal. The blends were: mogroside V and stevia RebM; stevia RebA and thaumatin; and sucralose and acesulfame-potassium (ace-K). At each 4 h visit, 60 healthy volunteers (53% male; all with overweight/obesity) consumed a 330 mL beverage with either an S&SE blend (0 kJ) or 8% sucrose (26 g, 442 kJ), shortly followed by a standardised breakfast (∼2600 or 1800 kJ with 77 or 51 g carbohydrates, depending on sex). All blends reduced the 2-h incremental area-under-the-curve (iAUC) for blood insulin (p < 0.001 in mixed-effects models), while the stevia RebA and sucralose blends reduced the glucose iAUC (p < 0.05) compared with sucrose. Post-prandial levels of triglycerides plus hepatic transaminases did not differ across conditions (p > 0.05 for all). Compared with sucrose, there was a 3% increase in LDL-cholesterol after stevia RebA-thaumatin (p < 0.001 in adjusted models); and a 2% decrease in HDL-cholesterol after sucralose-ace-K (p < 0.01). There was an impact of blend on fullness and desire to eat ratings (both p < 0.05) and sucralose-acesulfame K induced higher prospective intake vs sucrose (p < 0.001 in adjusted models), but changes were of a small magnitude and did not translate into energy intake differences over the next 24 h. Gastro-intestinal symptoms for all beverages were mostly mild. In general, responses to a carbohydrate-rich meal following consumption of S&SE blends with stevia or sucralose were similar to sucrose.

26 June 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GCGabriele Castelnuovo
Gabriele Castelnuovo
NPNuria Perez-Diaz-del-Campo
Nuria Perez-Diaz-del-Campo
CRChiara Rosso
Chiara Rosso
Angelo ArmandiAngelo Armandi
Angelo Armandi
Gian Paolo CavigliaGian Paolo Caviglia
Gian Paolo Caviglia
EBElisabetta Bugianesi
Elisabetta Bugianesi
Plant-based diets (PBDs) are gaining attention as a sustainable and health-conscious alternative for managing various chronic conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD). In the absence of pharmacological treatments, exploring the potential of lifestyle modifications to improve biochemical and pathological outcomes becomes crucial. The adoption of PBDs has demonstrated beneficial effects such as weight control, increased metabolic health and improved coexisting diseases. Nonetheless, challenges persist, including adherence difficulties, ensuring nutritional adequacy, and addressing potential deficiencies. The aim of this review is to provide a comprehensive overview of the impact of PBDs on MASLD, emphasizing the need for tailored dietary interventions with professional support to optimize their effectiveness in preventing and treating metabolic diseases.

27 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
NPNuria Perez-Diaz-del-Campo
Nuria Perez-Diaz-del-Campo
GCGabriele Castelnuovo
Gabriele Castelnuovo
Gian Paolo CavigliaGian Paolo Caviglia
Gian Paolo Caviglia
Angelo ArmandiAngelo Armandi
Angelo Armandi
CRChiara Rosso
Chiara Rosso
EBElisabetta Bugianesi
Elisabetta Bugianesi
Several features of the modern lifestyle, such as weekly schedules or irregular daily eating patterns, have become major drivers of global health problems, including non-alcoholic fatty liver disease (NAFLD). Sleep is an essential component of human well-being, and it has been observed that when circadian rhythms are disrupted, or when sleep quality decreases, an individual’s overall health may worsen. In addition, the discrepancy between the circadian and social clock, due to weekly work/study schedules, is called social jetlag and has also been associated with adverse metabolic profiles. Current management of NAFLD is based on dietary intake and physical activity, with circadian preferences and other environmental factors also needing to be taken into account. In this regard, dietary approaches based on chrononutrition, such as intermittent fasting or time-restricted feeding, have proven to be useful in realigning lifestyle behaviors with circadian biological rhythms. However, more studies are needed to apply these dietary strategies in the treatment of these patients. In this review, we focus on the impact of circadian rhythms and the role of sleep patterns on the pathogenesis and development of NAFLD, as well as the consideration of chrononutrition for the precision nutrition management of patients with NAFLD.

2 July 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
NPNuria Perez-Diaz-del-Campo
Nuria Perez-Diaz-del-Campo
GCGabriele Castelnuovo
Gabriele Castelnuovo
CRChiara Rosso
Chiara Rosso
ANAurora Nicolosi
Aurora Nicolosi
MGMarta Guariglia
Marta Guariglia
EBElisabetta Bugianesi
Elisabetta Bugianesi
Patients with non-alcoholic fatty liver disease (NAFLD) display impaired health-related quality of life (HRQoL) that is often linked to an unhealthy dietary pattern. The aim of this work was to investigate the impact of HRQoL and adherence to the Mediterranean diet on the risk of liver fibrosis (LF) in patients with NAFLD. LF was assessed in 244 patients through transient elastography (FibroScan®530. Echosens, Paris, France). Significant LF was defined according to liver stiffness measurements (LSM) values ≥ 7.1 kPa. The Mediterranean diet score and the Short Form-36 questionnaires were also completed. The median age was 54 (44–62) years and 57% of participants were male. A total of 42 (17.2%) participants had LSM ≥ 7.1 kPa and showed increased GGT (p = 0.001), glucose (p < 0.001), and triglycerides levels (p = 0.015) compared to those with LSM ≤7.0 kPa. Moreover, patients with significant LF had significantly lower scores related to Physical Functioning (p < 0.001) and Role Physical (p < 0.001). In the logistic regression analysis, lower role physical and lower adherence to the MedDiet (p = 0.001 and p = 0.009, respectively), after adjusting for age, diabetes, and obstructive sleep apnea, were associated with an increased risk of significant LF. Low adherence to MedDiet and low role physical may influence the risk of significant liver fibrosis in patients with NAFLD.